Alzamend Neuro, Inc.
ALZN • NASDAQ
Alzamend Neuro, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephan Jackman, with a market cap of $3.4M.
Market Cap$3.4M
Employees7.0
CEOStephan Jackman
CountryUnited States of America
Healthcare
Biotechnology
Financials
Alzamend Neuro, Inc. FAQ
Common questions about Alzamend Neuro, Inc.
Alzamend Neuro, Inc. has approximately 7 employees.